Literature DB >> 26445683

Valproate-Related Hyperammonemia in Older Adult Psychiatric Inpatients.

Lawrence W Adler, William T Regenold1.   

Abstract

Entities:  

Year:  2015        PMID： 26445683      PMCID： PMC4560181          DOI： 10.4088/PCC.14l01737

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  5 in total

1.  Valproate-induced hyperammonaemia.

Authors:  Michele Raja; Antonella Azzoni
Journal:  J Clin Psychopharmacol       Date:  2002-12       Impact factor: 3.153

2.  Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.

Authors:  Amit Chopra; Bhanu Prakash Kolla; Meghna P Mansukhani; Pamela Netzel; Mark A Frye
Journal:  Gen Hosp Psychiatry       Date:  2012-02-02       Impact factor: 3.238

Review 3.  Proceedings of a consensus conference for the management of patients with urea cycle disorders.

Authors:  M Summar; M Tuchman
Journal:  J Pediatr       Date:  2001-01       Impact factor: 4.406

4.  Hyperammonemia associated with valproic acid use in elderly psychiatric patients.

Authors:  Suzanne Holroyd; Jeffrey T Overdyke
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

Review 5.  Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749
  5 in total
  1 in total

Review 1.  Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report.

Authors:  Carlo Ignazio Cattaneo; Francesca Ressico; Roberta Valsesia; Pierluigi D'Innella; Matteo Ballabio; Michele Fornaro
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.